antipyrine has been researched along with epirubicin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Ackland, S; Farrell, G; Gebski, V; Gurney, HP | 1 |
| Hurkacz, M; Kotlarek-Haus, S; Orzechowska-Juzwenko, K; Usnarska-Zubkiewicz, L; Wiela-Hojenska, A | 1 |
1 trial(s) available for antipyrine and epirubicin
| Article | Year |
|---|---|
Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Antineoplastic Agents; Antipyrine; Biomarkers; Biotransformation; Epirubicin; Female; Half-Life; Humans; Leukemia, Myeloid, Acute; Liver; Male; Microsomes, Liver | 1999 |
3 other study(ies) available for antipyrine and epirubicin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Antipyrine; Bile Acids and Salts; Body Surface Area; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Humans; Liver Function Tests; Male; Middle Aged; Neutropenia | 1998 |